Valuation of the use of biomarkers predictive of drug efficacy to enrich responders in oncology drug clinical development
Thesis (S.M.)--Harvard-MIT Division of Health Sciences and Technology; and, (S.M.)--Massachusetts Institute of Technology, Sloan School of Management, 2006.
Main Author: | Wine, David |
---|---|
Other Authors: | A. Gregory Sorensen and Teodro Forcht Dagi. |
Format: | Thesis |
Language: | eng |
Published: |
Massachusetts Institute of Technology
2007
|
Subjects: | |
Online Access: | http://hdl.handle.net/1721.1/35679 |
Similar Items
-
Regression analysis of oncology drug licensing deal values
by: Hawkins, Paul Allen
Published: (2007) -
Assessing the impact of tumor evolution on oncology drug development and commercialization
by: Sterk, Joseph P. (Sterk, Joseph Phillip)
Published: (2011) -
The globalization of clinical drug development
by: Thiers, Fabio Albuquerque
Published: (2007) -
Mechanical loading impacts intramuscular drug transport : impact on local drug delivery
by: Wu, Peter I-Kung
Published: (2009) -
Investment performance of life-science venture capital investment funds, persistence, and subsector analysis
by: Behrens, Jeffrey S
Published: (2007)